Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $17,133,000 | $365,000 | $14,526,000 | $12,358,000 |
| Dep. & Amort. | $4,499,000 | $3,872,000 | $3,909,000 | $3,214,000 |
| Deferred Tax | -$1,249,000 | -$1,899,000 | -$1,568,000 | $187,000 |
| Stock-Based Comp. | $761,000 | $645,000 | $541,000 | $479,000 |
| Change in WC | -$3,667,000 | -$2,205,000 | -$2,782,000 | -$3,839,000 |
| Other Non-Cash | $3,991,000 | $12,228,000 | $4,469,000 | $1,710,000 |
| Operating Cash Flow | $21,468,000 | $13,006,000 | $19,095,000 | $14,109,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,372,000 | -$3,863,000 | -$4,388,000 | -$4,448,000 |
| Net Acquisitions | -$4,093,000 | -$12,032,000 | -$121,000 | -$12,907,000 |
| Inv. Purchases | -$519,000 | -$955,000 | -$1,204,000 | -$1,000 |
| Inv. Sales/Matur. | $377,000 | $1,658,000 | $721,000 | $1,026,000 |
| Other Inv. Act. | -$127,000 | $1,109,000 | $32,000 | -$225,000 |
| Investing Cash Flow | -$7,734,000 | -$14,083,000 | -$4,960,000 | -$16,555,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,309,000 | $4,184,000 | -$2,251,000 | $1,631,000 |
| Stock Issued | $0 | $0 | $384,000 | $0 |
| Stock Repurch. | -$1,306,000 | -$1,346,000 | $0 | -$840,000 |
| Dividends Paid | -$7,840,000 | -$7,445,000 | -$7,012,000 | -$6,610,000 |
| Other Fin. Act. | -$195,000 | -$203,000 | -$240,000 | $8,412,000 |
| Financing Cash Flow | -$7,032,000 | -$4,810,000 | -$9,119,000 | $2,593,000 |
| Forex Effect | -$293,000 | $23,000 | -$410,000 | -$133,000 |
| Net Chg. in Cash | $6,409,000 | -$5,864,000 | $4,606,000 | $14,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,909,000 | $12,773,000 | $8,167,000 | $8,153,000 |
| End Cash | $13,318,000 | $6,909,000 | $12,773,000 | $8,167,000 |
| Free Cash Flow | $18,096,000 | $9,143,000 | $14,707,000 | $9,661,000 |